Gland Pharma Q4 Results: Net profit more than doubles to Rs 192.4 crore

The company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.